Suppression of estrogens with Aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: A review R. J. Santen Review Pages: 183 - 202
Karyotype analysis of a human mammary sarcoma explant in vitro T. R. ChenG. Seman Reports Pages: 203 - 208
Estradiol stimulates synthesis of a major intracellular protein in a human breast cancer cell line (MCF-7) Dean P. EdwardsDavid J. AdamsWilliam L. McGuire Reports Pages: 209 - 223
The prophylaxis of rat and mouse mammary gland tumorigenesis by suppression of prolactin secretion: A reappraisal Clifford W. WelschMargaret Goodrich-SmithLeslie Roth Reports Pages: 225 - 232
Prolactin binding by human mammary carcinoma: Relationship to estrogen receptor protein concentration and patient age Barbara Rae-VenterTakuma NemotoThomas L. Dao Reports Pages: 233 - 243
Oestrogen receptor concentration in primary breast cancer and axillary node metastases Richard Anthony HawkinsRobert BlackAndrew Patrick McEwan Forrest Reports Pages: 245 - 251
Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer Armando BertuzziMaria Grazia DaidoneRosella Silvestrini Reports Pages: 253 - 262
Tumour steroid hormone synthesis and estrogen receptor status in breast cancer patients R. C. MasonD. A. BurnsA. P. M. Forrest Reports Pages: 263 - 266
Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions W. R. MillerV. HumeniukA. P. M. Forrest Reports Pages: 267 - 272
Repeat screening by single oblique view mammography Bengt LundgrenSören Jakobsson Reports Pages: 273 - 280
Glycosylated haemoglobin levels in breast cancer patients receiving cytotoxic chemotherapy B. CantwellI. F. ShirleyJ. J. Fennelly Correspondence Pages: 281 - 282
